Video

VIDEO: A practical protocol for monitoring discoid lupus


 

FROM SDEF WOMEN’S & PEDIATRIC DERMATOLOGY SEMINAR

References

NEWPORT BEACH, CALIF.– Patients with discoid lupus should be checked routinely for systemic disease, but complete autoantibody studies aren’t necessary for those patients with a prior work-up and a documented negative antinuclear antibodies, according to Dr. Ruth Ann Vleugels.

“The reason why we are doing these investigations is because between 5% and up to about 20% of our discoid lupus patients can develop systemic disease,” said Dr. Vleugels of Brigham and Women’s Hospital in Boston, Mass. Some patients don’t develop symptoms until years later, she noted.

In an interview at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar, Dr. Vleugels shared her protocol for managing discoid lupus patients. She had no financial conflicts to disclose. SDEF and this news organization are owned by Frontline Medical Communications.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

hsplete@frontlinemedcom.com

Recommended Reading

Look to presentation, not pathology, for dermatomyositis diagnosis
MDedge Rheumatology
Drug combos for psoriatic arthritis upped shingles risk
MDedge Rheumatology
High-resolution MRI revealed enthesitis in PsA patients with dactylitis
MDedge Rheumatology
VIDEO: Dr. Alan Menter discusses apremilast’s approval for psoriasis
MDedge Rheumatology
Psoriasis severity linked to uncontrolled hypertension
MDedge Rheumatology
In psoriasis, is pushing for PASI 90 really worthwhile?
MDedge Rheumatology
Secukinumab showed sustained efficacy in psoriasis
MDedge Rheumatology
FDA panel unanimously supports secukinumab approval for psoriasis
MDedge Rheumatology
Select biologics for dose escalation in psoriasis
MDedge Rheumatology
Psoriasiform lesions linked to anti-TNF treatment
MDedge Rheumatology